BioPharma Credit PLC (BPCR) — Free Cash Flow Generation Index

Latest as of June 2025: 1.00x

BioPharma Credit PLC (BPCR) has a Free Cash Flow Generation Index of 1.00x as of June 2025. Free cash flow of $33.76 Million represents 1% of operating cash flow ($33.76 Million). See BioPharma Credit PLC short-term liquidity ratio to evaluate short-term liquidity relative to the company's equity base.

FCF Generation Index

1.00x
Free Cash Flow / Operating CF

Free Cash Flow

$33.76 Million
USD

Operating Cash Flow

$33.76 Million
USD

Capital Expenditures

$0.00
USD

BioPharma Credit PLC Free Cash Flow Generation Index (2017–2024)

Historical FCF Generation Index trend for BioPharma Credit PLC across 8 annual periods. Explore BPCR debt coverage from operations to assess how comfortably operating cash covers total debt obligations.

Annual Free Cash Flow Generation for BioPharma Credit PLC (2017–2024)

Year-by-year Free Cash Flow Generation Index for BioPharma Credit PLC. For the full company profile including market capitalisation, see BPCR market cap overview.

Year FCG Index Free Cash Flow (USD) Operating CF Capital Expenditures YoY Change
2024 1.00x $111.91 Million $111.91 Million $0.00 ▲ +0.0%
2023 1.00x $123.18 Million $123.18 Million $0.00 ▲ +0.0%
2022 1.00x $184.28 Million $184.28 Million $0.00 ▲ +0.0%
2021 1.00x $96.44 Million $96.44 Million $0.00 ▲ +0.0%
2020 1.00x $58.07 Million $58.07 Million $0.00 ▲ +0.0%
2019 1.00x $131.52 Million $131.52 Million $0.00 ▲ +0.0%
2018 1.00x $67.14 Million $67.14 Million $0.00 ▲ +0.0%
2017 1.00x $23.07 Million $23.07 Million $0.00
FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).